The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.20
Bid: 50.00
Ask: 50.20
Change: 1.35 (2.76%)
Spread: 0.20 (0.40%)
Open: 49.00
High: 50.30
Low: 49.00
Prev. Close: 48.85
WJG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Statement

17 Nov 2016 07:00

RNS Number : 3933P
Watkin Jones plc
17 November 2016
 

For immediate release

17 November 2016

 

Watkin Jones plc

('Watkin Jones' or the 'Group')

 

Pre-Close Trading Statement

 

Watkin Jones plc (AIM:WJG), a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector, is pleased to provide a trading update for the year ended 30 September 2016 (the 'period').

 

The Board expects to report a successful financial year with trading in line with its expectations.

 

As announced on 27 September 2016, Watkin Jones successfully completed, ahead of the 2016/17 academic year, ten developments across the UK with a total of 3,819 student beds. Watkin Jones has a record of on-time delivery of schemes and all developments expected to be completed ahead of the 2017/2018 academic year, remain on track. The Group continues to add sites to its strong development pipeline and, at 30 September 2016, it had a total of 21 developments with 6,814 beds targeted for delivery during 2017 and 2018.

 

The Group's pipeline beyond 2018 is also looking robust with over 2,000 beds across a number of sites already secured. This includes the proposed redevelopment of the Duncan House site in Stratford, London, to provide 511 beds of student accommodation, 44 residential apartments and approximately 28,000 square feet of academic and office space. The scheme has a gross development value in excess of £100 million and is due for delivery in 2019.

 

Fresh Student Living, the Group's asset management subsidiary, continues to progress well, and now has 12,337 beds under management for the 2016/17 academic year (8,310 under management during the 2015/16 academic year).

 

The pipeline going forward provides the Group with strong visibility of earnings and cash flows and underpins our strategy in the near term. As a result, and with interest from investors in Purpose Built Student Accommodation remaining consistently strong, the Board remains confident in the outlook for the Group.

 

Mark Watkin Jones, Chief Executive Officer of Watkin Jones plc, said: "It has been a busy year for the Group and excellent progress has been made. Not only have we delivered 3,819 beds across ten sites in the UK, but we have also successfully made the transition to being a public company. Our performance in the year reinforces the attractiveness of our end-to-end business model to investors, whilst our development pipeline continues to provide excellent visibility of earnings and cashflow."

 

The Group will be announcing its Final Results on Wednesday, 18 January 2017. An analyst briefing will be held at 09.30hrs at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

 

- Ends -

 

For further information:

Watkin Jones plc

 

Mark Watkin Jones, Chief Executive Officer

Tel: +44 (0) 1248 362 516

Phil Byrom, Chief Financial Officer

www.watkinjonesplc.com

 

 

Zeus Capital Limited (Nominated Adviser & Joint Broker)

 

Corporate Finance

 

Dan Bate / Nick Cowles / Jamie Peel

Tel: +44 (0) 161 831 1512

Corporate Broking

Tel: +44 (0) 20 3829 5000

Dominic King / Benjamin Robertson

www.zeuscapital.co.uk

 

 

Peel Hunt LLP (Joint Broker)

Tel: +44 (0) 20 7418 8900

Mike Bell / Matthew Brooke-Hitching

www.peelhunt.com

 

 

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Richard Oldworth / Jamie Hooper

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

 

Notes to Editors

 

Watkin Jones is a leading UK developer and constructor of multi occupancy property assets, with a focus on the student accommodation sector. The Group has strong relationships with institutional investors, and a good reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered over 31,800 student beds across 98 sites, making it a key player and leader in the UK purpose built student accommodation market. In addition, Watkin Jones has been responsible for over 50 residential developments, ranging from starter homes to executive housing and apartments.

 

The Group's competitive advantage lies in its experienced management team and business model, which enables it to offer an end to end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset. Key components of the business model are:

 

· Site identification - extensive experience of site identification and acquisition facilitates high quality sites being acquired;

· Planning consents - in depth knowledge and experience of the planning consent process specific to this type of asset facilitates high success rates on planning applications;

· In-house construction and delivery - in-house construction expertise, management and delivery limits reliance on third parties and, together with favourable contractual relationships with key suppliers, enhances control of cost;

· Funding structure - forward sale model reduces risk for Watkin Jones and provides security and visibility of the asset pipeline for investors. The Group has strong relationships with blue chip investors, including a number that are repeat investors in Watkin Jones developments; and

· Asset management - dedicated property management division provides a continued service solution to investors post development completion and completes the 'end to end' business model.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFFIFWMFMSEDF
Date   Source Headline
2nd May 20247:00 amRNSPresentation via Investor Meet Company
23rd Apr 20247:00 amRNSAppointment of CFO
23rd Apr 20247:00 amRNSHY24 Trading Update
15th Mar 20243:42 pmRNSDirector/PDMR Shareholding
7th Mar 20244:05 pmRNSForward Sale of PBSA Development in Bristol
29th Feb 20245:17 pmRNSResult of AGM
9th Feb 20243:30 pmRNSNotification of Major Holdings
1st Feb 20242:15 pmRNSAnnual Report and Notice of AGM
31st Jan 20241:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSPresentation via Investor Meet Company
10th Jan 20247:00 amRNSNotice of Final Results
14th Dec 20237:00 amRNSChange of Registered Office
16th Nov 20236:20 pmRNSNotification of Major Holdings
15th Nov 20237:00 amRNSAppointment of Chief Executive Officer
24th Oct 20233:46 pmRNSNotification of Major Holdings
19th Oct 202312:43 pmRNSNotification of Major Holdings
12th Oct 20232:24 pmRNSDirector Shareholding
11th Oct 20231:16 pmRNSDirector Shareholding
11th Oct 20237:00 amRNSFY23 Trading Update
3rd Oct 20234:23 pmRNSNotification of Major Holdings
3rd Oct 20234:18 pmRNSCorrection: Notification of Major Holdings
1st Sep 20238:00 amRNSNotification of Major Holdings
17th Aug 20237:00 amRNSSale of three non-core PRS operational assets
19th Jul 20232:52 pmRNSDirector Shareholding
19th Jul 20237:00 amRNSBoard Change
19th Jul 20237:00 amRNSTrading Update
22nd Jun 20233:53 pmRNSNotification of Major Holdings
5th Jun 20237:00 amRNSSuccessful £155m forward sale with L&G and Clanmil
24th May 20237:00 amRNSDirector Shareholding
23rd May 20237:10 amRNSHalf Year Results
15th May 202310:45 amRNSIssue of Equity
13th Apr 20237:00 amRNSH1-2023 Trading Update
28th Feb 20234:00 pmRNSResults of AGM
17th Feb 20237:00 amRNSDirector/PDMR Shareholding
14th Feb 20233:31 pmRNSDirector Shareholding
8th Feb 20237:00 amRNSPresentation via Investor Meet Company
6th Feb 20237:00 amRNSDirector/PDMR Shareholding
2nd Feb 202312:30 pmRNSAnnual Report and Notice of AGM
31st Jan 202312:20 pmRNSDirector Shareholding
27th Jan 202310:51 amRNSProgressive publishes new research
25th Jan 20237:00 amRNSFull Year Results 2022
16th Jan 20232:15 pmRNSNotification of Major Holdings
9th Jan 20237:00 amRNSNotice of Results
13th Oct 202210:27 amRNSProgressive publishes new research
11th Oct 20229:40 amRNSNotification of Major Holdings
10th Oct 20227:00 amRNSBoard Appointments
5th Oct 202212:47 pmRNSDirector Shareholding
4th Oct 20224:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSFY-2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.